Status:
COMPLETED
Wound Infiltration With Bupivacaine/Adrenalin During Cesarean Section and Postoperative Pain.
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Cesarean Section
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Thus study evaluates the advantage of infiltration of the surgical wound by local anesthetics in cesarean section on post operative pain relief. In the study group before closing the skin, both sides ...
Detailed Description
Cesarean section is one of the most common procedures in the world. There is an advantage in preventing pain after cesarean section, as opposed to treating pain that has already started. The infiltrat...
Eligibility Criteria
Inclusion
- cesarean section with regional anesthesia
- singleton
- pfannenstiel incision
Exclusion
- cesarean section with general anesthesia
- maternal liver or kidney disease
- allergy to Bupivacaine
- allergy to Adrenalin
- intrauterine fetal death
- major fetal malformations
Key Trial Info
Start Date :
January 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT03395912
Start Date
January 25 2018
End Date
June 30 2021
Last Update
October 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HaEmek medical center
Afula, Israel